Omega-3 Drug Vascepa Slows Progress of Heart Disease, New Study from The Lundquist Institute Shows

several clear pills on a table top
Tuesday, November 19, 2019
Investigator(s): Matthew Budoff, MD

PHILADELPHIA — Findings from a new study provide a promising pathway toward reducing the impact of heart disease, as the data shows that Vascepa, a drug derived from omega-3 oils that is commonly used to treat hypertriglyceridemia, a disease that causes elevated fat levels in blood, also reduces the progression of heart disease.

Read more

For Detecting the Harmful Effects of HIV and Improving the Lives of COPD Patients, The Lundquist Institute Honors Two Physician-Scientists for Groundbreaking Research

Drs. Margaret A. Keller and Richard Casaburi
Wednesday, November 13, 2019
Investigator(s): Margaret Keller, MD, Richard Casaburi, PhD, MD

LOS ANGELES – The Lundquist Institute, one of the nation’s leading nonprofit biomedical research institutes, hosted its 16th Annual Legends celebration on November 12 honoring two highly distinguished researchers for their groundbreaking innovations and outstanding service in finding solutions to the most pressing medical problems of our day.

Read more

Vaping Causes Lung Damage in Just 3 Days of Use, New Study Says

Vape on a table with smoke swirling around
Wednesday, November 6, 2019
Investigator(s): Virender Rehan, MD

LOS ANGELES — E-cigarette use, or vaping, can damage lungs in as little as three days of use, according to a new study from The Lundquist Institute (formerly known as LA BioMed) and the University of Rochester.

Read more